Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac).
Article Details
- CitationCopy to clipboard
Garcia-Colunga J, Awad JN, Miledi R
Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac).
Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):2041-4.
- PubMed ID
- 9050901 [ View in PubMed]
- Abstract
Fluoxetine (Prozac), a widely used antidepressant, is said to exert its medicinal effects almost exclusively by blocking the serotonin uptake systems. The present study shows that both muscle and neuronal nicotinic acetylcholine receptors are blocked, in a noncompetitive and voltage-dependent way, by fluoxetine, which also increases the rate of desensitization of the nicotinic receptors. Because these receptors are very widely distributed in the both central and peripheral nervous systems, the blocking action of fluoxetine on nicotinic receptors may play an important role in its antidepressant and other therapeutical effects. Our findings will help to understand the mode of action of fluoxetine, and they may also help to develop more specific medicinal drugs.
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Fluoxetine Neuronal acetylcholine receptor subunit alpha-2 Protein Humans UnknownAntagonistDetails Fluoxetine Neuronal acetylcholine receptor subunit alpha-3 Protein Humans UnknownAntagonistDetails Fluoxetine Neuronal acetylcholine receptor subunit beta-4 Protein Humans UnknownAntagonistDetails